CD4 and neoplasm: CAFs induce and recruit regulatory T cells (Tregs) to repress antitumor immune responses and support tumor progression by the induction of CD4+ helper T (TH) lymphocytes to strengthen pro-tumorigenic TH2 and TH17 phenotypes [107,108].